CARECLOUD INC (CCLD) Stock Fundamental Analysis
NASDAQ:CCLD - Nasdaq - US14167R1005 - Common Stock - Currency: USD
CCLD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Health Care Technology industry. CCLD has only an average score on both its financial health and profitability. CCLD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CCLD had negative earnings in the past year.
In the past year CCLD had a positive cash flow from operations.
CCLD had negative earnings in each of the past 5 years.
CCLD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCLD's Return On Assets of -5.12% is amongst the best of the industry. CCLD outperforms 80.56% of its industry peers.
Looking at the Return On Equity, with a value of -6.96%, CCLD belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 15.91%, CCLD belongs to the top of the industry, outperforming 97.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.12% | ||
| ROE | -6.96% | ||
| ROIC | 15.91% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CCLD has a Operating Margin of 10.13%. This is amongst the best in the industry. CCLD outperforms 88.89% of its industry peers.
CCLD's Operating Margin has improved in the last couple of years.
The Gross Margin of CCLD (45.67%) is worse than 63.89% of its industry peers.
In the last couple of years the Gross Margin of CCLD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.13% | ||
| PM (TTM) | N/A | ||
| GM | 45.67% |
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
2. Health
2.1 Basic Checks
CCLD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CCLD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCLD has more shares outstanding
Compared to 1 year ago, CCLD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.16 indicates that CCLD is not in any danger for bankruptcy at the moment.
CCLD has a better Altman-Z score (4.16) than 77.78% of its industry peers.
CCLD has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
CCLD has a better Debt to FCF ratio (0.01) than 86.11% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CCLD is not too dependend on debt financing.
CCLD's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. CCLD outperforms 69.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 4.16 |
ROIC/WACC1.54
WACC10.33%
2.3 Liquidity
A Current Ratio of 1.69 indicates that CCLD should not have too much problems paying its short term obligations.
CCLD has a Current ratio of 1.69. This is comparable to the rest of the industry: CCLD outperforms 47.22% of its industry peers.
CCLD has a Quick Ratio of 1.65. This is a normal value and indicates that CCLD is financially healthy and should not expect problems in meeting its short term obligations.
CCLD has a Quick ratio of 1.65. This is comparable to the rest of the industry: CCLD outperforms 47.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
CCLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.03%, which is quite impressive.
The Revenue has decreased by -0.45% in the past year.
CCLD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.47% yearly.
EPS 1Y (TTM)81.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%6.43%
3.2 Future
CCLD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.81% yearly.
Based on estimates for the next years, CCLD will show a small growth in Revenue. The Revenue will grow by 4.18% on average per year.
EPS Next Y151%
EPS Next 2Y67.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.95%
Revenue Next 2Y4.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCLD. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 14.77, which indicates a correct valuation of CCLD.
Based on the Price/Forward Earnings ratio, CCLD is valued cheaper than 88.89% of the companies in the same industry.
CCLD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.49.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.77 |
4.2 Price Multiples
CCLD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CCLD is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCLD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.95 | ||
| EV/EBITDA | 3.78 |
4.3 Compensation for Growth
CCLD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CCLD's earnings are expected to grow with 67.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.81%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CCLD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CCLD (6/27/2025, 8:00:02 PM)
2.41
+0.13 (+5.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.73%
Inst Owner ChangeN/A
Ins Owners14.34%
Ins Owner Change6.01%
Market Cap101.99M
Analysts80
Price Target4.51 (87.14%)
Short Float %1.46%
Short Ratio1.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)60.78%
Min EPS beat(2)21.57%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)-41.12%
Min EPS beat(4)-357.52%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)-16.18%
EPS beat(12)8
Avg EPS beat(12)-4.32%
EPS beat(16)12
Avg EPS beat(16)5.81%
Revenue beat(2)1
Avg Revenue beat(2)2.25%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)5.6%
Revenue beat(4)1
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)5.6%
Revenue beat(8)1
Avg Revenue beat(8)-3.14%
Revenue beat(12)1
Avg Revenue beat(12)-3.28%
Revenue beat(16)4
Avg Revenue beat(16)-1.86%
PT rev (1m)6%
PT rev (3m)-0.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.77 | ||
| P/S | 0.91 | ||
| P/FCF | 6.95 | ||
| P/OCF | 4.7 | ||
| P/B | 1.88 | ||
| P/tB | 5.63 | ||
| EV/EBITDA | 3.78 |
EPS(TTM)-0.22
EYN/A
EPS(NY)0.16
Fwd EY6.77%
FCF(TTM)0.35
FCFY14.39%
OCF(TTM)0.51
OCFY21.27%
SpS2.66
BVpS1.28
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.12% | ||
| ROE | -6.96% | ||
| ROCE | 20.14% | ||
| ROIC | 15.91% | ||
| ROICexc | 18.08% | ||
| ROICexgc | 65.54% | ||
| OM | 10.13% | ||
| PM (TTM) | N/A | ||
| GM | 45.67% | ||
| FCFM | 13.05% |
ROA(3y)-32.11%
ROA(5y)-24.15%
ROE(3y)-57.71%
ROE(5y)-41.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y52.71%
ROICexcg growth 5Y104.32%
ROICexc growth 3Y91.65%
ROICexc growth 5Y92.03%
OM growth 3Y59.79%
OM growth 5Y95.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.11%
GM growth 5Y4.51%
F-Score7
Asset Turnover1.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 50.58% | ||
| Cap/Sales | 6.23% | ||
| Interest Coverage | 28.5 | ||
| Cash Conversion | 85.88% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | 4.16 |
F-Score7
WACC10.33%
ROIC/WACC1.54
Cap/Depr(3y)74.91%
Cap/Depr(5y)76.9%
Cap/Sales(3y)8.36%
Cap/Sales(5y)8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y151%
EPS Next 2Y67.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y-7.4%
Revenue growth 5Y11.47%
Sales Q2Q%6.43%
Revenue Next Year0.95%
Revenue Next 2Y4.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y416.02%
EBIT growth 3Y47.96%
EBIT growth 5Y117.42%
EBIT Next Year208.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.65%
FCF growth 3Y68.43%
FCF growth 5Y21.21%
OCF growth 1Y13.67%
OCF growth 3Y15.69%
OCF growth 5Y22.06%